Yahoo! FinanceHome - Yahoo! - Help

Market Guide

[ Stock Screener | Company & Fund Index | Financial Glossary ]

Profile - Novitron Int'l, Inc. (NasdaqSC:NOVI)
As of 31-Aug-2001
Enter symbol:
symbol lookup

 
More Info: Quote | Chart | News | Profile | SEC | Msgs | Insider
Upcoming Events
Sep 21Dividend payment of $0.01
Location
One Gateway Center, Suite 411
Newton, MA 02458
Phone: (617) 527-9933
Email: info@novitronintl.com
Employees (last reported count): 88
Financial Links
 ·Top Institutional Holders
 ·Top Mutual Fund Holders
 ·Historical Quote Data
 ·Raw SEC Filings at sec.gov
Competitors:
 ·Sector: Technology
 ·Industry: Scientific & Technical Instr.
Company Websites
 ·Home Page
 ·Yahoo! Category

 ·Search Yahoo! for related links...

Ownership
·Insider and 5%+ Owners: 58%
·Over the last 6 months:
 · 5 insider buys; 61.0K shares (7.8% of insider shares)
·Institutional: 6% (15% of float)
(6 institutions)
·Net Inst. Buying: 55.0K shares (+37.67%)
(prior quarter to latest quarter)
More From Market Guide
 ·Highlights
 ·Performance
 ·Ratio Comparisons
Business Summary
Novitron International, Inc. is a multinational corporation that produces scientific instrumentation used in medical, veterinary, and analytical laboratories and in industrial process monitoring. The Company's Dutch subsidiary, Vital Scientific NV, designs and manufactures scientific and clinical laboratory instrumentation marketed worldwide through distributors and strategic partnerships. The Company's Australian subsidiary, Vital Diagnostics Pty. Ltd., distributes diagnostic instruments and assays in the South Pacific and has entered into a strategic alliance with Medical Innovations Limited for the development of immunoassay diagnostics. The Company's Dutch subsidiary, NovaChem BV, develops and markets process monitors with applications in petrochemical and pharmaceutical production and in environmental monitoring.
More from Market Guide: Expanded Business Description

Financial Summary
Novitron International, Inc. designs, manufactures and markets scientific instrumentation used in medical, veterinary, and analytical laboratories and in industrial process monitoring. For the fiscal year ended 3/31/01, revenues decreased 9% to $12.9 million. Net income totalled $403 thousand, up from $108 thousand. Revenues reflect lower HYTEC 288 and Selectra by Vital Scientific sales. Earnings were offset by the absence of a $75 thousand restructuring charge.

Recent Earnings Announcement
For the 3 months ended 06/30/2001, revenues were 2,959; after tax earnings were 76. (Preliminary; reported in thousands of dollars.)

More from Market Guide: Significant Developments

Officers[Insider Trade Data]
FY2000 Compensation
PayExer

Israel Stein, M.D., 57
Chairman, Pres, CEO and Treasurer
$185K--  
Emile Hugen, 55
Managing Director of Vital Scientific NV
89K--  
Adrian Tennyenhuis, 49
Sr. VP
123K$13K
Dollar amounts are as of 31-Mar-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.; "Exer" is the value of options excercised during the fiscal year.
More from Market Guide on Officers & Directors:
Expanded List, Bios, Compensation, Options
Statistics at a Glance -- NasdaqSC:NOVIAs of 31-Aug-2001
Price and Volume
52-Week Low
on 24-Oct-2000
$1.50 
Recent Price$5.20 
52-Week High
on 16-July-2001
$10.21 
Beta-0.44 
Daily Volume (3-month avg)2,500 
Daily Volume (10-day avg)0 
Stock Performance
[one-year price graph]
big chart [1d | 5d | 3m | 6m | 1y | 2y | 5y | max]
52-Week Change+77.0%
52-Week Change
relative to S&P500
+137.4%
Share-Related Items
Market Capitalization$7.51M
Shares Outstanding1.45M
Float600.0K
Dividends & Splits
Annual Dividend (indicated)$0.04 
Dividend Yield0.77%
Last Split: 11 for 10 on 11-Mar-1998
Per-Share Data
Book Value (mrq*)$2.82 
Earnings (ttm)$0.27 
Earnings (mrq)$0.05 
Sales (ttm)$8.65 
Cash (mrq*)$1.07 
Valuation Ratios
Price/Book (mrq*)1.84 
Price/Earnings (ttm)18.98 
Price/Sales (ttm)0.60 
Income Statements
Sales (ttm)$12.9M
EBITDA (ttm*)$72.0K
Income available to common (ttm)$405.0K
Profitability
Profit Margin (ttm)3.1%
Operating Margin (ttm)-4.3%
Fiscal Year
Fiscal Year EndsMar 31
Most recent quarter
(fully updated)
31-Mar-2001
Most recent quarter
(flash earnings)
30-June-2001
Management Effectiveness
Return on Assets (ttm)4.97%
Return on Equity (ttm)10.04%
Financial Strength
Current Ratio (mrq*)1.76 
Debt/Equity (mrq*)0.01 
Total Cash (mrq)$0 
Short Interest
As of 8-Aug-2001
Shares Short2,000 
Percent of Float0.3%
Shares Short
(Prior Month)
0 
Short Ratio0.50 
Daily Volume4,000 
See Profile Help for a description of each item above;   K = thousands;   M = millions;   mrq = most-recent quarter;   ttm = trailing twelve months;   (as of 30-June-2001, except mrq*/ttm* items as of 31-Mar-2001)

Market Guide offers more in-depth Company Research, Stock Screening, and Hottest Stocks and Industries on over 10,000 U.S. Equities.


Copyright © 2001 Yahoo! Inc. All Rights Reserved. Privacy Policy - Terms of Service
Company information Copyright Market Guide. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Market Guide, CSI, etc.) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.